SIGHT SCIENCES, INC. (SGHT) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 20.50M USD | Liabilities, Current |
| Cash and equivalents | 79.75M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 11.39M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 5.70M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $20.50M | $79.75M | (m) | $11.39M | $5.70M | (m) |
| 2026-03-31 | (m) | $18.16M | $84.96M | (m) | $10.60M | $7.01M | (m) |
| 2025-12-31 | (m) | $11.03M | $91.97M | (m) | $9.74M | $7.77M | (m) |
| 2025-09-30 | (m) | $11.83M | $92.37M | (m) | $9.74M | $7.98M | (m) |
| 2025-06-30 | (m) | $11.94M | $101.50M | (m) | $9.61M | $6.21M | (m) |
| 2025-03-31 | (m) | $12.12M | $108.77M | (m) | $9.42M | $5.80M | (m) |
| 2024-12-31 | (m) | $15.47M | $120.36M | (m) | $10.79M | $6.33M | (m) |
| 2024-09-30 | (m) | $13.80M | $118.56M | (m) | $12.93M | $6.09M | (m) |
| 2024-06-30 | (m) | $13.29M | $118.18M | (m) | $19.92M | $6.78M | (m) |
| 2024-03-31 | (m) | $11.69M | $127.28M | (m) | $15.64M | $6.87M | (m) |
| 2023-12-31 | (m) | $12.25M | $138.13M | (m) | $14.29M | $7.85M | (m) |
| 2023-09-30 | (m) | $14.33M | $144.50M | (m) | $16.92M | $9.24M | (m) |
| 2023-06-30 | (m) | $14.05M | $154.51M | (m) | $18.10M | $7.91M | (m) |
| 2023-03-31 | (m) | $15.14M | $167.34M | (m) | $16.36M | $7.14M | (m) |
| 2022-12-31 | (m) | $17.82M | $185.00M | (m) | $15.15M | $6.11M | (m) |
| 2022-09-30 | (m) | $17.39M | $199.82M | (m) | $12.59M | $5.52M | (m) |
| 2022-06-30 | (m) | $14.20M | $220.10M | (m) | $10.47M | $4.94M | (m) |
| 2022-03-31 | (m) | $12.00M | $238.59M | (m) | $9.95M | $4.08M | (m) |
| 2021-12-31 | (m) | $13.50M | $260.69M | (m) | $8.71M | $3.48M | (m) |
| 2021-09-30 | (m) | $10.31M | $271.48M | (m) | $8.92M | $2.95M | (m) |
| 2021-06-30 | (m) | $12.06M | $35.57M | (m) | $6.89M | $2.58M | (m) |
| 2020-12-31 | (m) | $9.31M | $61.51M | (m) | $5.36M | $2.60M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |